Filing Flows › Xenetic Biosciences (XBIO) › Q1 2026 › vs Q4 2025
Xenetic Biosciences (XBIO) Q1 2026 vs Q4 2025 (quarter over quarter)
Xenetic Biosciences's revenue rose $41K (+5%) from $766K in Q4 2025 to $807K in Q1 2026.
Xenetic Biosciences, Q1 2026: revenue $807K (+36% year over year), operating margin -62.2%, net loss $456K, operating cash flow −$536K. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $807K | $766K | $41K | +5% |
| Other income, net | $46K | $44K | $2K | +4% |
| Net loss | $456K | $579K | −$123K | -21% |
| Costs & expenses | $1.3M | $1.4M | −$80K | -6% |
| Operating costs | $1.3M | $1.4M | −$80K | -6% |
| Research & development | $661K | $773K | −$112K | -14% |
| General & admin | $648K | $616K | $32K | +5% |
| Operating cash sources | $548K | $257K | $291K | +113% |
| Share-based compensation | $11K | $14K | −$3K | -19% |
| Cash used in operations | $536K | $243K | $294K | +121% |
| Net loss absorbed | $456K | $579K | −$123K | -21% |
| Working capital & other | $91K | −$322K | $414K | — |
Questions
How much did Xenetic Biosciences's revenue grow quarter over quarter in Q1 2026?
Xenetic Biosciences's revenue rose $41K (+5%) from $766K in Q4 2025 to $807K in Q1 2026.